219 related articles for article (PubMed ID: 32353687)
1. CD30L/CD30 signaling regulates the formation of the tumor immune microenvironment and inhibits intestinal tumor development of colitis-associated colon cancer in mice.
Wang X; Gao Y; Zhang X; Wang X; Wang B; Meng X; Yoshikai Y; Wang Y; Sun X
Int Immunopharmacol; 2020 Jul; 84():106531. PubMed ID: 32353687
[TBL] [Abstract][Full Text] [Related]
2. CD30 ligand is a target for a novel biological therapy against colitis associated with Th17 responses.
Sun X; Yamada H; Shibata K; Muta H; Tani K; Podack ER; Iwakura Y; Yoshikai Y
J Immunol; 2010 Dec; 185(12):7671-80. PubMed ID: 21068411
[TBL] [Abstract][Full Text] [Related]
3. CD30 ligand deficiency accelerates glioma progression by promoting the formation of tumor immune microenvironment.
Duan J; Gao Y; Zhang X; Wang X; Wang B; Meng X; Yoshikai Y; Wang Y; Sun X
Int Immunopharmacol; 2019 Jun; 71():350-360. PubMed ID: 30952099
[TBL] [Abstract][Full Text] [Related]
4. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y
Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
[TBL] [Abstract][Full Text] [Related]
5. CD30 ligand/CD30 plays a critical role in Th17 differentiation in mice.
Sun X; Yamada H; Shibata K; Muta H; Tani K; Podack ER; Yoshikai Y
J Immunol; 2010 Aug; 185(4):2222-30. PubMed ID: 20639486
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effects of lentinan on inflammatory bowel disease and colitis-associated cancer.
Liu Y; Zhao J; Zhao Y; Zong S; Tian Y; Chen S; Li M; Liu H; Zhang Q; Jing X; Sun B; Wang H; Sun T; Yang C
J Cell Mol Med; 2019 Feb; 23(2):750-760. PubMed ID: 30472806
[TBL] [Abstract][Full Text] [Related]
7. Tropomyosin 2 Regulates Tumor Cell Proliferation, Immune Suppression, and Activation of the JNK Signaling Pathway in Colitis-Associated Cancer (CAC).
Sun A; Ge J; Ding K; Gao Z; Zhang Y
Discov Med; 2024 Apr; 36(183):778-787. PubMed ID: 38665026
[TBL] [Abstract][Full Text] [Related]
8. Critical roles of CD30/CD30L interactions in murine autoimmune diabetes.
Chakrabarty S; Nagata M; Yasuda H; Wen L; Nakayama M; Chowdhury SA; Yamada K; Jin Z; Kotani R; Moriyama H; Shimozato O; Yagita H; Yokono K
Clin Exp Immunol; 2003 Sep; 133(3):318-25. PubMed ID: 12930356
[TBL] [Abstract][Full Text] [Related]
9. CD30 ligand is a new therapeutic target for central nervous system autoimmunity.
Shinoda K; Sun X; Oyamada A; Yamada H; Muta H; Podack ER; Kira J; Yoshikai Y
J Autoimmun; 2015 Feb; 57():14-23. PubMed ID: 25533628
[TBL] [Abstract][Full Text] [Related]
10. A novel role of CD30L/CD30 signaling by T-T cell interaction in Th1 response against mycobacterial infection.
Tang C; Yamada H; Shibata K; Muta H; Wajjwalku W; Podack ER; Yoshikai Y
J Immunol; 2008 Nov; 181(9):6316-27. PubMed ID: 18941223
[TBL] [Abstract][Full Text] [Related]
11. CD30L is involved in the regulation of the inflammatory response through inducing homing and differentiation of monocytes via CCL2/CCR2 axis and NF-κB pathway in mice with colitis.
Mei C; Meng F; Wang X; Yan S; Zheng Q; Zhang X; Fu W; Xue J; Wang S; He Y; Sun X; Jiang X; Wang Y
Int Immunopharmacol; 2022 Sep; 110():108934. PubMed ID: 35834956
[TBL] [Abstract][Full Text] [Related]
12. CD30L/CD30 is critical for maintenance of IL-17A-producing γδ T cells bearing Vγ6 in mucosa-associated tissues in mice.
Sun X; Shibata K; Yamada H; Guo Y; Muta H; Podack ER; Yoshikai Y
Mucosal Immunol; 2013 Nov; 6(6):1191-201. PubMed ID: 23549449
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of PD-1 follows tumour development in the AOM/DSS model of inflammation-induced colorectal cancer in mice.
Yassin M; Sadowska Z; Djurhuus D; Nielsen B; Tougaard P; Olsen J; Pedersen AE
Immunology; 2019 Sep; 158(1):35-46. PubMed ID: 31429085
[TBL] [Abstract][Full Text] [Related]
14. Madecassic acid alleviates colitis-associated colorectal cancer by blocking the recruitment of myeloid-derived suppressor cells via the inhibition of IL-17 expression in γδT17 cells.
Yun X; Zhang Q; Fang Y; Lv C; Chen Q; Chu Y; Zhu Y; Wei Z; Xia Y; Dai Y
Biochem Pharmacol; 2022 Aug; 202():115138. PubMed ID: 35700756
[TBL] [Abstract][Full Text] [Related]
15. CD30L/CD30 protects against psoriasiform skin inflammation by suppressing Th17-related cytokine production by Vγ4
Yue D; You Y; Zhang X; Wang B; Wang X; Qi R; Yang F; Meng X; Yoshikai Y; Wang Y; Sun X
J Autoimmun; 2019 Jul; 101():70-85. PubMed ID: 31005389
[TBL] [Abstract][Full Text] [Related]
16. T lymphocyte SHP2-deficiency triggers anti-tumor immunity to inhibit colitis-associated cancer in mice.
Liu W; Guo W; Shen L; Chen Z; Luo Q; Luo X; Feng G; Shu Y; Gu Y; Xu Q; Sun Y
Oncotarget; 2017 Jan; 8(5):7586-7597. PubMed ID: 27935860
[TBL] [Abstract][Full Text] [Related]
17. MUC1-mediated Macrophage Activation Promotes Colitis-associated Colorectal Cancer via Activating the Interleukin-6/ Signal Transducer and Activator of Transcription 3 Axis.
Sheng YH; Davies JM; Wang R; Wong KY; Giri R; Yang Y; Begun J; Florin TH; Hasnain SZ; McGuckin MA
Cell Mol Gastroenterol Hepatol; 2022; 14(4):789-811. PubMed ID: 35809803
[TBL] [Abstract][Full Text] [Related]
18. TIPE2 Promotes Tumor Initiation But Inhibits Tumor Progression in Murine Colitis-Associated Colon Cancer.
Etwebi Z; Goldsmith JR; Bou-Dargham M; Tian Y; Hood R; Spitofsky N; Li M; Sun H; Lou Y; Liu S; Lengner C; Chen YH
Inflamm Bowel Dis; 2022 May; 28(5):764-774. PubMed ID: 34894222
[TBL] [Abstract][Full Text] [Related]
19. Effects of triptolide on the sphingosine kinase - Sphingosine-1-phosphate signaling pathway in colitis-associated colon cancer.
Li H; Xing X; Zhang X; Li L; Jiang Z; Wang T; Huang X; Wang X; Zhang L; Sun L
Int Immunopharmacol; 2020 Nov; 88():106892. PubMed ID: 32810834
[TBL] [Abstract][Full Text] [Related]
20. T-Cell-Specific CerS4 Depletion Prolonged Inflammation and Enhanced Tumor Burden in the AOM/DSS-Induced CAC Model.
El-Hindi K; Brachtendorf S; Hartel JC; Oertel S; Birod K; Merz N; Trautmann S; Thomas D; Weigert A; Schäufele TJ; Scholich K; Schiffmann S; Ulshöfer T; Utermöhlen O; Grösch S
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
